INCR – intercure ltd. (US:NASDAQ)
Stock Stats
News
InterCure (NASDAQ:INCR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
InterCure (NASDAQ:INCR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow [Yahoo! Finance]
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow
Form 6-K Intercure Ltd. For: Dec 18
Form SCHEDULE 13D Intercure Ltd. Filed by: Rabinovich Alexander
Form 6-K Intercure Ltd. For: Nov 25
Form 6-K Intercure Ltd. For: Nov 03
Form 6-K Intercure Ltd. For: Oct 08
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.